Oxford Global, London, UK
24 - 25 April 2019
Day 1 – Market Access Strategies, Opportunities and Commercial Challenges Day 2 – Developing Biosimilars and Biobetters – Manufacturing and Bio-Analytics
|
|
|
Invited Speakers:
|
|
Ian Henshaw, Vice President, Global Head of Business Unit Biogen
Anjan Selz, Vice President, Head of Biosimilars, EMEA Lupin
Bernd Liedert, Senior Director, Clinical Development Biosimilars Boehringer Ingelheim
|
|